LEO 27847

DRUG3 trials

Sponsors

LEO Pharma

Conditions

HealthyRenal ImpairmentSecondary Hyperparathyroidism

Phase 1

LEO 27847 - A Study in Healthy Male Subjects

CompletedNCT01007383

LEO PharmaHealthy

Start: 2009-09-30End: 2010-04-30Updated: 2025-02-24

The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847

CompletedNCT01141179

LEO PharmaRenal Impairment

Start: 2010-05-31End: 2011-02-28Updated: 2025-02-24

LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients

CompletedNCT01167309

LEO PharmaSecondary Hyperparathyroidism

Start: 2010-06-30End: 2011-12-31Updated: 2025-02-24